e-Nicotine Technology (eNT) today announced details regarding its family
of products aimed at helping smokers as they transition off of
combustible cigarettes. Having recently completed clinical trials in
nearly 100 smokers and showing rapid (within 1-minute), dramatic (up to
83% reduction) and sustained smoking urge reduction, eNT is moving
forward toward the launch of its family of state-of-the-art electronic
nicotine delivery products.
Products Have No Secondhand Vapor, Do not Look Like Cigarettes, Provide a Satisfying Nicotine Experience (Photo: Business Wire)
“We believe that our products are poised to capture a significant market
share given that they can be marketed at a substantially lower cost, can
be used discreetly, and will help consumers rid themselves of a habit
that has been shortening lives for decades,” said Jeff Williams, Chief
Executive Officer of eNT. “Additionally, our product platform is
amendable to eventual development as a more traditional nicotine
replacement therapy (NRT), which are marketed for smoking cessation by
pharmaceutical companies like GlaxoSmithKline, Johnson & Johnson,
Novartis, and Pfizer. For our initial product, we will be launching
commercially across Europe first.”
eNT’s technology enables the development of products that do not look
like cigarettes or e-cigarettes and emit no secondhand vapor, which
prevents family members or the public from being exposed to the thick
plumes of chemicals from existing e-cigarettes, giving users a
satisfying and discreet nicotine experience anytime, anywhere. eNT’s
initial launch product includes a reusable electronic controller that
comes standard with an interface to proprietary mobile e-health tools
allowing each user to carefully track their usage and help them to
transition completely off of cigarettes and nicotine if they choose.
Existing electronic cigarettes such as NJOY, blu eCigs (NYSE:LO),
MarkTen (NYSE:MO), and Victory electronic cigarettes (OTCMKTS:ECIG) rely
exclusively on a form factor that intentionally mimics traditional
combustible cigarettes, such as those from British American Tobacco
(NYSEMKT:BTI), Lorillard (NYSE:LO), Phillip Morris (NYSE:PM), and
Reynolds American (NYSE:RAI). As a result, many public health and
tobacco control experts have noted that e-cigs risk re-glamorizing
smoking behavior: “By developing a family of electronic nicotine
delivery devices that do not look like cigarettes, emit no secondhand
vapor, and provide a consistent dose with each inhalation, we are
pursuing an important and novel approach to helping smokers,” said Dr.
Michael Hufford, Chief Medical Officer of eNT.
About e-Nicotine Technology
eNT is a healthcare company committed to reducing the harms associated
with combustible tobacco products. eNT is developing the next generation
of state-of-the-art electronic nicotine delivery products that quickly
and dramatically reduce smoking urge while using 40-70% less nicotine
than cigarettes or existing e-cigarettes. eNT’s products deliver
consistent doses of nicotine and emit no secondhand vapor, giving
consumers a discreet and satisfying nicotine experience anytime,
anywhere.
For more information about eNT, its technology, products and other
inquiries, please contact: Justin Bingham, VP Corporate Development at
+1.801.502.3458 or jbingham@enicotinetechnology.com,
http://www.enicotinetechnology.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140310005777/en/
Copyright Business Wire 2014